What to expect from pharma at the JPM conference
Heidi Overton, Novo Nordisk CEO Maziar Mike Doustdar, Eli Lilly CEO David A. Ricks, and U.S. Secretary of Commerce Howard...
HEALTH & FITNESS
Abivax’s stock surged to become a prime biotech takeover target
Europe's best-performing blue-chip stock in 2025 is widely expected to be bought by a larger peer, in a deal analysts...
Patient advocates urge U.S. court to halt AFP prescription operations
In a photo illustration, prescription drugs are seen next to a pill bottle on July 23, 2024 in New York.Spencer...
CNBC launches initiative to help 30 million Americans rare diseases
Thirty million. It's a big number. Maybe not in the context of business news, where we usually talk about company...
OpenAI launches ChatGPT Health to connect user medical records
OpenAI CEO Sam Altman attends an event to pitch AI for businesses in Tokyo, Feb. 3, 2025.Kim Kyung-hoon | ReutersOpenAI...
First GLP-1 pill for obesity from Novo Nordisk launches in the U.S.
The logo of pharmaceutical company Novo Nordisk is displayed in front of its offices in Bagsvaerd, on the outskirts of...
These stocks will benefit from new habits
The ripple is about to become a wave. Right now, there are numerous barriers for people who are considering treating...
Eli Lilly investors shouldn’t sweat rival Novo Nordisk having the first obesity pill on sale
Jim Cramer says don't sweat Novo Nordisk's head start over Club holding Eli Lilly in the obesity pill market. Eli...
Wegovy-maker Novo Nordisk shares surge after GLP-1 pill approval
Shares in Novo Nordisk surged 6% Tuesday, after the Wegovy maker secured approval of its GLP-1 pill — a world...
FDA approves first GLP-1 pill for obesity from Novo Nordisk
The logo of pharmaceutical company Novo Nordisk is displayed in front of its offices in Bagsvaerd, on the outskirts of...
How donors, access and polls led Trump to reclassify marijuana
President Donald Trump's move Thursday to sign an executive order easing federal restrictions on marijuana — and clearing the way...
Wall Street deals 2025 under Trump: Tariffs, uncertainty slow M&A
The Wall Street Bull statue covered in snow on Nov. 15, 2018.Erik Mcgregor | Lightrocket | Getty ImagesWall Street expected...
UnitedHealth Group releases results of independent audit
UnitedHealthcare sign is displayed at its office building in Minnetonka, Minnesota, U.S., Dec. 11, 2025. Tim Evans | ReutersUnitedHealth Group...
Trump reclassifies cannabis to Schedule III, easing weed restrictions
U.S. President Donald Trump sits in the Oval Office to sign executive orders, at the White House in Washington, D.C.,...
Eli Lilly obesity pill maintains weight loss after Wegovy, Zepbound
Eli Lilly on Thursday said its closely watched obesity pill helped patients maintain the majority of their weight loss after...
Medline debuts on Nasdaq after biggest IPO of 2025
Shares of U.S. medical supplies giant Medline jumped more than 22% in its debut on the Nasdaq on Wednesday after...
Obesity pills from Novo Nordisk, Eli Lilly are coming
Daniel Grill | Tetra Images | Getty ImagesA version of this article first appeared in CNBC's Healthy Returns newsletter, which...
Pfizer 2026 guidance shows Metsera, Seagen deals will take time to pay off
Smith Collection | Archive Photos | Getty ImagesPfizer on Tuesday forecast modest 2026 guidance as it looks to longer-term investments...
Why Wall Street and Jim Cramer think Danaher stock is ‘ready to go for a romp’
Danaher is finally turning the corner. CNBC's Jim Cramer sees it. Wall Street does, too. The life sciences stock is...
Trump confirms potential drug reclassification, but stocks slide
Bill Schmitt Jr. (C) joins cannabis reform protesters outside the White House to call on U.S. President Joe Biden "to...
